Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis

被引:19
|
作者
Spagni, Gregorio [1 ,2 ]
Gastaldi, Matteo [3 ]
Businaro, Pietro [3 ,4 ]
Chemkhi, Zeineb [1 ]
Carrozza, Cinzia [5 ]
Mascagna, Giovanni [5 ]
Falso, Silvia [1 ]
Scaranzin, Silvia [3 ]
Franciotta, Diego [6 ]
Evoli, Amelia [1 ,2 ]
Damato, Valentina [1 ,7 ]
机构
[1] Univ Cattolica Sacro Cuore, Dept Neurosci, Milan, Italy
[2] Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy
[3] IRCCS Mondino Fdn, Neuroimmunol Lab, Milan, Italy
[4] Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy
[5] Fdn Policlin Gemelli, IRCCS, Chem Biochem & Clin Mol Biol Unit, Rome, Country Country, Italy
[6] IRCCS Osped Policlin San Martino, Autoimmunol Lab, Genoa, Italy
[7] Univ Florence, Dept Neurosci Drugs & Child Hlth, Florence, Italy
来源
关键词
ACETYLCHOLINE-RECEPTOR ANTIBODY; DIAGNOSTIC-TEST;
D O I
10.1212/NXI.0000000000200038
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and ObjectivesLive cell-based assay (CBA) can detect acetylcholine receptors (AChRs) or muscle-specific tyrosine kinase (MuSK) antibodies (Abs) in a proportion of patients with radioimmunoassay (RIA)-double seronegative myasthenia gravis (dSN-MG). A commercial fixed CBA for AChR and MuSK Abs has recently become available; however, comparative studies on fixed and live CBAs are lacking. In this study, we compared the performance of fixed and live CBAs in patients with RIA-dSN MG and assessed their sensitivity in RIA-positive MG samples and their specificity.MethodsAChR and MuSK Abs were tested in 292 serum samples from 2 Italian MG referral centers by live and fixed CBAs: 192 from patients with MG and 100 from controls. All samples had been previously assessed by RIA: 66 were AChR positive, 40 MuSK positive, and 86 dSN. All controls were negative. Two independent raters assessed the CBA results. Fixed and live CBAs were compared with the McNemar test; interrater and interlaboratory agreement were assessed with Cohen's kappa or interclass correlation coefficient (ICC), as appropriate.ResultsIn 86 RIA-dSN samples, fixed CBA detected Abs in 10 cases (11.6%, 95% CI 5.7-20.3), whereas live CBA detected Abs in 16 (18.6%, 95% CI 11.0-28.5) (p = 0.0143). Of these sera, those positive by fixed CBA were also positive by live CBA. In addition, live CBA could detect MuSK Abs in 4 and AChR Abs in 2 samples that were negative by fixed CBA, providing an 8% (95% CI 2.9-16.6) further increase in the Ab detection rate. These results were confirmed by flow cytometry. In the RIA-positive cohort, the sensitivity for AChR Abs was 98.5% (95% CI 91.9%-99.9%) for fixed CBA and 100% (95% CI 94.6-100) for live CBA (p = 0.1573). For both assays, the sensitivity for MuSK Abs was 100% (95% CI 91.2-100), and the specificity was 100% (95% CI 96.4-100). Interrater agreement was almost perfect for live and fixed CBAs (Cohen's kappa 0.972 and 0.978, respectively), alike interlaboratory agreement. Interrater agreement for the CBA score ranged from good to excellent (ICC: 0.832-0.973).DiscussionFixed CBA represents a valuable alternative to RIA for AChR and MuSK Ab detection in patients with MG and could be considered as a first-step diagnostic test. Live CBA can be useful in the serologic evaluation of RIA- and fixed CBA-negative samples.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Cell-Based Assay for the Detection of Anti- MuSK Antibodies in Myasthenia Gravis Patients′ Sera
    Bouchtout, N.
    Touil-Boukoffa, C.
    Attal, N.
    Phillips, W.
    Raache, R.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 : 45 - 45
  • [2] A novel MuSK cell-based myasthenia gravis diagnostic assay
    Han, Jiaojiao
    Zhang, Jing
    Li, Mingqiang
    Zhang, Yingna
    Lv, Jie
    Zhao, Xue
    Wang, Shumin
    Wang, Lulu
    Yang, Haonan
    Han, Sensen
    Fang, Hua
    Gao, Feng
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2019, 337
  • [3] Comparison of fixed cell-based assay to radioimmunoprecipitation assay for acetylcholine receptor antibody detection in myasthenia gravis
    Mirian, Ario
    Nicolle, Michael W.
    Edmond, Pamela
    Budhram, Adrian
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2022, 432
  • [4] Comparison of Fixed Cell-based Assay to Radioimmunoprecipitation Assay for Acetylcholine Receptor Antibody Detection in Myasthenia Gravis
    Mirian, Ario
    Nicolle, Michael
    Budhram, Adrian
    [J]. NEUROLOGY, 2022, 99 (23) : S72 - S72
  • [5] Validation of a Live Cell-Based Assay For Antibodies to Clustered Acetlycholine Receptor Antibodies in Myasthenia Gravis
    Cruz, Anna
    Frykman, Hans
    [J]. NEUROLOGY, 2020, 94 (15)
  • [6] Comparison of fixed and live cell based assay for the serological diagnosis of Myasthenia Gravis
    Spagni, G.
    Monte, G.
    Chemkhi, Z.
    Falso, S.
    Evoli, A.
    Damato, V.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 506 - 506
  • [7] COMPARISON OF FIXED AND LIVE CELL BASED ASSAY FOR THE SEROLOGICAL DIAGNOSIS OF MYASTHENIA GRAVIS
    Spagni, Gregorio
    Monte, Gabriele
    Chemkhi, Zeineb
    Falso, Silvia
    Evoli, Amelia
    Damato, Valentina
    [J]. MUSCLE & NERVE, 2022, 65 : S21 - S21
  • [8] Detection of Antibodies against the Acetylcholine Receptor in Patients with Myasthenia Gravis: A Comparison of Two Enzyme Immunoassays and a Fixed Cell-Based Assay
    Gambino, Caterina Maria
    Agnello, Luisa
    Ciaccio, Anna Maria
    Scazzone, Concetta
    Vidali, Matteo
    Di Stefano, Vincenzo
    Milano, Salvatore
    Brighina, Filippo
    Candore, Giuseppina
    Lo Sasso, Bruna
    Ciaccio, Marcello
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (14)
  • [9] Clinically biphasic myasthenia gravis with both AChR and MuSK antibodies
    Sanjeev Rajakulendran
    Stuart Viegas
    Jennifer Spillane
    Robin S. Howard
    [J]. Journal of Neurology, 2012, 259 : 2736 - 2739
  • [10] Clinically biphasic myasthenia gravis with both AChR and MuSK antibodies
    Rajakulendran, Sanjeev
    Viegas, Stuart
    Spillane, Jennifer
    Howard, Robin S.
    [J]. JOURNAL OF NEUROLOGY, 2012, 259 (12) : 2736 - 2739